BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 21295930)

  • 1. Evaluation of incidentally discovered adrenal masses with PET and PET/CT.
    Wong KK; Arabi M; Bou-Assaly W; Marzola MC; Rubello D; Gross MD
    Eur J Radiol; 2012 Mar; 81(3):441-50. PubMed ID: 21295930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive evaluation of the incidentally detected indeterminate adrenal mass.
    Al-Hawary MM; Francis IR; Korobkin M
    Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):277-92. PubMed ID: 15763701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PET in the surgical approach to adrenal disease.
    Gross MD; Gauger PG; Djekidel M; Rubello D
    Eur J Surg Oncol; 2009 Nov; 35(11):1137-45. PubMed ID: 19243910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological evaluation of adrenal incidentalomas: current methods and future prospects.
    McDermott S; O'Connor OJ; Cronin CG; Blake MA
    Best Pract Res Clin Endocrinol Metab; 2012 Feb; 26(1):21-33. PubMed ID: 22305450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cavernous hemangioma: rare incidentaloma of the adrenal gland].
    de la Villéon B; Goudard Y; Peroux E; Jacquet SF; Aubert P; Duverger V
    Prog Urol; 2011 Dec; 21(13):961-4. PubMed ID: 22118362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic evaluation of incidentally discovered adrenal masses.
    Willatt JM; Francis IR
    Am Fam Physician; 2010 Jun; 81(11):1361-6. PubMed ID: 20521756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
    Hennings J; Hellman P; Ahlström H; Sundin A
    Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary imaging of incidentally discovered adrenal masses.
    Wale DJ; Wong KK; Viglianti BL; Rubello D; Gross MD
    Biomed Pharmacother; 2017 Mar; 87():256-262. PubMed ID: 28063406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
    Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
    Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients.
    Boland GW; Blake MA; Holalkere NS; Hahn PF
    AJR Am J Roentgenol; 2009 Apr; 192(4):956-62. PubMed ID: 19304700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scintigraphic localization of adrenal tumors.
    Gross MD; Djekidel M; Hay RV; Rubello D
    Minerva Endocrinol; 2009 Jun; 34(2):171-84. PubMed ID: 19333218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal masses of varied etiology: anatomical and molecular imaging features on PET-CT.
    Sharma P; Singh H; Dhull VS; Suman KC S; Kumar A; Bal C; Kumar R
    Clin Nucl Med; 2014 Mar; 39(3):251-60. PubMed ID: 24217551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidentally-discovered adrenal masses.
    Gross MD; Korobkin M; Bou-Assaly W; Rubello D
    Discov Med; 2010 Jan; 9(44):24-33. PubMed ID: 20102682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
    Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
    Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of adding (18)F-FDG PET/CT to adrenal protocol CT for characterizing adrenal metastasis (≥ 10 mm) in oncologic patients.
    Park SY; Park BK; Kim CK
    AJR Am J Roentgenol; 2014 Feb; 202(2):W153-60. PubMed ID: 24450697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant lesions.
    Maurea S; Mainolfi C; Bazzicalupo L; Panico MR; Imparato C; Alfano B; Ziviello M; Salvatore M
    AJR Am J Roentgenol; 1999 Jul; 173(1):25-9. PubMed ID: 10397094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
    Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
    Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of molecular imaging in the personalized approach of patients with adrenal masses.
    Lorusso M; Rufini V; DE Crea C; Pennestrì F; Bellantone R; Raffaelli M
    Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):104-115. PubMed ID: 35343669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The indeterminate adrenal mass in patients with cancer.
    Sahdev A; Reznek RH
    Cancer Imaging; 2007 Oct; 7 Spec No A(Special issue A):S100-9. PubMed ID: 17921094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.